Aura Biosciences Target Price

Analysts' average 12-month price target for Aura Biosciences is $18.

Get informed when a big investor buys or sells

+ Follow

Share Price

$6.18

Average Target Price

$18.00

191.3% upside

1 analysts in the last 4 months

High: $18 | Low: $18

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-08-11	H.C. Wainwright	$18	191.3% upside
2026-05-12	Leerink Partners	$17	175.1% upside
2025-03-26	JMP SecuritiesJonathan Wolleben	$19	207.4% upside
2025-03-25	H.C. WainwrightEdward White	$25	304.5% upside
2024-10-18	ScotiabankGeorge Farmer	$23	272.2% upside
2024-10-18	H.C. WainwrightEd White II	$22	256% upside
2024-10-18	BTIGJulian Harrison	$24	288.3% upside
2024-07-25	H.C. WainwrightEdward White	$21	239.8% upside
2022-11-11	JMP Securities	$30	385.4% upside

Aura Biosciences (AURA) FAQ

Aura Biosciences posts a target price of $18. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

A target price of $18 for AURA means covering analysts, on average, see the stock 191.3% upside of $6.18 over about 12 months. Dig into who set the high and low targets and how recently they updated — freshness matters as much as the average itself.

Context for AURA's target price usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Aura Biosciences's other metric pages and overview cover the third.